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This paper presents the first automated system for simultaneously detecting human papilloma,
herpes simplex, adenovirus, or cytomegalovirus viral antigens and gene sequences in standard
formalin-fixed, paraffin-embedded tissue substrates and tissue culture. These viruses can be
detected by colorimetric in situ nucleic acid hybridization, using biotinylated DNA probes, or by
indirect immunoperoxidase techniques, using polyclonal or monoclonal antibodies, in a 2.0-hour
assay performed at a single automated robotic workstation.
INTRODUCTION
The accurate diagnosis of viral pathogens in cells, cellular extracts, and standard
histopathology specimens is one of the leading research goals in cell biology and
investigative anatomic pathology. The application of molecular probes to the problem
of viral diagnosis in formalin-fixed, paraffin-embedded tissues began in 1983, when
Brigati et al. [1] described the firstsuccessful detection ofviralgenomic information in
these substrates by in situ DNA hybridization using biotin-labeled deoxyribonucleic
acid (DNA) probes. Several papers have since compared and contrasted the use of
molecular probes and antibody-directed techniques for their specificity and sensitivity
in detecting viruses in formalin-fixed, paraffin-embedded tissues [2,3,4,5], but none of
these papers has shown a single method by which both of these techniques can be
employed simultaneously. Recently, ourdevelopment ofthe first automated system for
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tissue antigen [6] and gene [7] detection in formalin-fixed tissue sections provided the
opportunity for our laboratory finally tounify and streamline these previously separate
approaches into a single system for the accurate diagnosis of viral pathogens in 2.0
hours or less, by either molecular hybridization or immunologic techniques. For the
first time, the cell biologist, clinical virologist, or surgical pathologist can combine the
accuracy of genetic and immunologic diagnostic approaches into a single automated
tissue-detection system or can use them separately.
MATERIALS AND METHODS
Tissue Substrates
Formalin-fixed, paraffin-embedded tissue blocks from various surgical and autopsy
specimens of cases known to be infected with herpes simplex virus types 1 and 2,
adenovirus types 2 and 5 [1], papillomavirus, or cytomegalovirus (CMV) were
obtained from the paraffin archives of the Department of Pathology at Penn State's
Milton S. Hershey Medical Center or the Memorial Sloan-Kettering Cancer Center.
Serial five-micron sections were cut from these blocks and were used for either
immunocytochemistry or in situ DNA hybridization. Adenovirus-infected A549 cells
were grown on cover slips as previously reported [1].
Standard hematoxylin- and eosin-stained slides from all cases werereviewed prior to
the study. The control cases of herpes simplex virus, adenovirus, and cytomegalovirus
studied were backed by positive isolation ofthe pathogen in tissue culture. Other cases
were used based upon a positive clinical history ofexposure, the presence ofsignificant
positive serology, and the observation of morphologically characteristic viral inclu-
sions. The cases of papillomavirus were all vulvar condylomas, and the diagnosis was
madeby the presenceofkoilocytotic atypia. Oneofthese cases contained dysplasia and
in situ squamous cell carcinoma in the adjacent squamous epithelium.
Reagents
The reagents used were those previously described [6,7], with the following
significant modifications. The distilled water with 2.5 ml BRIJ per liter in station 2
(Fig. 2) contained 25 percent methanol. The automation buffer in station 10 had 25
percent acetoneadded toit. Both ofthesechangesappeared toimprovecapillary action
as well as to decrease background staining. We found that eliminating the blocking
protein before the primary antibody or after the biotin-labeled DNA probe reduced
nonspecific staining.
The following were purchased as products of Fisher Scientific Company: reagent
alcohol (Catalog No. A-962-4), acetone (Catalog No. A18-500), methanol (Catalog
No. A-412-500), Hemo-De (Catalog No. 15-182-507), 30 percent hydrogen peroxide
(Catalog No. A-325-500), BRIJ 35 (Catalog No. BP345-500), and a 50-slide holder
(Catalog No. 15-185-293). The following items were purchased from Fisher Scientific
Company as products of Biomeda Corporation: aqueous hematoxylin (Catalog No.
BM-M1O), Probe Wash (Catalog No. BM-M38), lOx automation buffer (Catalog
No. BM-M30), primary antibody diluent (Catalog No. BM-M35), peroxidase reagent
(Catalog No. BM-M32), peroxide/chromogen kit (Catalog No. BM-S01), Auto/
Zyme (Catalog No. BM-M34), Crystal Mount (Catalog No. BM-M02), and predi-
luted rabbit anti-herpes simplex types 1 and 2 antibody (Catalog No. BM-304M). The
following products were obtained from Sigma: pepsin (Catalog No. P 7012) and
p-iodonitrotetrazolium violet (Catalog No. I-8377). Pronase was obtained from
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Calbiochem Inc. (Catalog No. 53702). The following items were purchased as
products of DAKO Corporation: rabbit anti-bovine papilloma virus antibody (Catalog
No. B580), monoclonal mouse anti-cytomegalovirus antibody (Catalog No. M-757),
and alkaline phosphatase-conjugated avidin (Catalog No. D365). Rabbit anti-
adenovirus antibodies against common hexon antigen were kindly provided by Dr.
Goran Wadell, University of Umea, Sweden. Biotinylated probes for herpes simplex 1
and 2, cytomegalovirus, and adenovirus were purchased from ENZO Biochem, Inc.
(Catalog Nos. EBP-838, EBP-835, and EBP-834, respectively). Probes for papillo-
mavirus types 6, 11, 16, and 18 were obtained from Life Technologies, Inc. (Catalog
No. 42061020). The following items were purchased as products from AMRESCO: 45
percent formamide hybridization cocktail (Catalog No. P0652), 5-bromo-4-chloro-
3-indoyl phosphate p-toliudine salt (Catalog No. 0885), and dimethylformamide
(Catalog No. P0046440).
Automated Instrumentation
Viral detection was performed with the Fisher Code-On Automated Molecular
Pathology system, according to significant modifications of our previously described
methods [6,7]. The system consists ofan IBM System 11-directed triaxial robotic unit,
which is contained under a portable fume hood (Fig. 1). The robotic unit transports
slides with tissue sections immobilized on them among 20 different stations. Figure 2
shows the basic reagent format for the unit. The mostimportant aspectofthisformat is
that these computer-assisted, triaxial robotic units can simultaneously perform viral
localization with antibody or probe detection without any changes in the reagent
set-up.
The Code-On molecular pathology system utilizes capillary action to perform
automated immunocytochemistry or in situ DNA hybridization [6,7]. A 150-micron
capillary gap is formed by apposing the painted surfaces of two specially made
Probe-On glass slides (Fisher Scientific Co. Catalog No. 15-187M). The pairs ofslides
forming thecapillary gaps are mounted in aspecialized holder, which can hold up to 60
slides, and the robotic arm of the unit moves the slide holder through a programmed
series ofreagents which are taken up and expelled by capillary action (Fig. 3) [6].
As Fig. 2 shows, the stations are labeled 0 to 19 and include a low-temperature
incubation chamber which can achieve temperatures as high as 550 Centigrade, a
high-temperature oven which can achieve temperatures as high as 1100 Centigrade,
and a cool-down chamber. In stations 1 through 7, as well as in station 10, all of the
slides in the holder are treated identically. This portion is the batch analysis part ofthe
assay, and it includes dewaxing, hydrating, and buffer washing. In these stations, a
single vessel containing a common reagent is employed; this one reagent fills all the
capillary gaps simultaneously. In stations 13 through 15, the discrete analysis part of
the assay is performed. The tissues in individual capillary gaps can be treated with
different enzymes, probes, antibodies, ordetection systems in these stations by employ-
ing a reagent isolon [6], which divides the station into 30 separate caplet-shaped wells,
which can be filled with about 150 to 200 microliters of the particular reagent in
question. The hydrophobicity ofthe isolon allows the reagent to bead up, and therefore
a specific capillary gap will easily pick up a separate reagent. Since the robotic slide
holder has a capacity of 60 slides, arranged in 30 capillary gaps, the machine can
process 30 different probes or antibodies simultaneously in one run at the rate of one
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TABLE 1
The Virocode Program
PROGRAM:
Virocode TECH: DJB DATE: 07/22/88
Station Time
Event No. Hold (minutes) Mix Temp (OC) Solution
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
y
N
N
N
N
N
N
y
N
N
N
y
y
N
N
N
N
N
N
y
N
N
N
N
y
N
N
N
N
N
Clear
80 Denature oven
Pad
Clear
Pad
Clear
Pad
Reagent alcohol
Pad
Reagent alcohol
Pad
Methanol peroxide
Pad
Methanol peroxide
Pad
95% alcohol
Pad
Buffer
Pad
Enzyme
40 Chamber
Pad
95% alcohol
Pad
Buffer
Pad
Primary
48 Chamber
Pad
Buffer
Pad
Detection system
48 Chamber
Pad
Buffer
Pad
Distilled water
Pad
Chromogen
46 Chamber
Pad
Distilled water
Pad
Chromogen
46 Chamber
Pad
Distilled water
Pad
Hematoxylin
001
002
003
004
005
006
007
008
009
010
011
012
013
014
015
016
017
018
019
020
021
022
023
024
025
026
027
028
029
030
031
032
033
034
035
036
037
038
039
040
041
042
043
044
045
046
047
048
049
06 Y
19 N
12 N
06 N
12 N
06 N
12 N
05 N
12 N
05 N
12 N
04 N
12 N
04 N
12 N
03 N
12 N
10 N
08 N
13 N
18 N
09 N
03 N
08 N
10 N
11 N
14 N
18 N
09 N
10 N
09 N
15 N
18 N
09 N
10 N
09 N
02 N
09 N
16 N
18 N
09 N
02 N
09 N
16 N
18 N
09 N
02 N
09 N
01 N
1.0
10.0
0.5
0.1
0.5
0.1
0.5
1.0
0.3
1.0
0.3
0.1
0.3
8.0
0.3
0.1
0.3
0.1
0.1
1.0
10.0
1.0
0.1
0.3
0.1
0.5
0.5
15.0
1.0
0.1
0.3
1.0
15.0
1.0
0.1
0.5
0.1
1.0
0.3
5.0
1.0
0.1
1.0
0.5
5.0
1.0
0.1
0.5
1.5
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TABLE 1-Continued
PROGRAM:
Virocode TECH: DJB DATE: 07/22/88
Station Time
Event No. Hold (minutes) Mix Temp (OC) Solution
050 09 N 0.5 N Pad
051 02 N 0.1 N Distilled water
052 09 N 1.0 N Pad
053 02 N 0.3 N Distilled water
054 11 N 0.5 N Pad
055 10 N 0.6 N Buffer
056 11 N 0.5 N Pad
057 02 N 0.1 N Distilled water
058 11 N 0.5 N Pad
Total time for completion - 92.4 minutes = 1.6 hours
probe or antibody per capillary gap. Special glass reagent isolons without depressions
were developed in order to limit the amount ofprobe used for in situ hybridization.
Viral Antigen Detection
When immunocytochemistry was performed alone, we used methods described by
Brigati et al. [6] with modification. Basically, five-micron sections from formalin-
fixed, paraffin-embedded tissues were cut, floated on a 420 Centigrade water bath
containing no protein or subbing solution, and placed on specially treated silanized
Probe-On glass slides [8]. The slides were air dried at room temperature and then
heated vertically in a 50-slide holder in an 800 Centigrade convection oven for ten
minutes. Heating theslides in the oven immobilized thetissuesections andinitiated the
dewaxing process. After the slides had been cooled back to room temperature, they
were placed in the specialized Code-On slide holder in capillary gap formation (Fig.
3).
The basic Virocode program for viral antigen detection required slightly more than
one and a half hours to run (Table 1). One of the most crucial steps for the antibody
method was the initial dewaxing step. Antigens from tissues that were not adequately
deparaffinized did not stain well. The tissues were cleared with Hemo-De in the
high-temperature oven at 800 Centigrade for ten minutes; this use of Hemo-De in the
high-temperature oven allowed safeandcompletedewaxing becauseofthehigh boiling
point ofthe reagent. After hydration with reagent alcohol, endogenous peroxidase was
blocked with a mixture of methanol and 3 percent hydrogen peroxide [6]. Enzyme
digestion was necessary to demonstrate CMV in formalin-fixed tissue sections. Freshly
prepared pronase was used at 10 mg/ml in 1 x automation buffer for ten minutes at
400 Centigrade to produce the most intense nuclear localization of CMV. Decreasing
the amount of pronase produced a smaller number of antigen-positive cells. The
pronase was stable and worked in temperatures as high as 550 Centigrade. 1 x
automation buffer alone was used on the tissues infected with herpes and papillomavi-
rus during the enzyme step, as the localization oftheseviral antigens was not improved
by trypsin, pepsin, or pronase digestion. The Auto/Zyme system [6] was employed to
localize the adenovirus hexon antigen.
Rabbit anti-bovine papilloma virus antibody and monoclonal mouse anti-cytomega-
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TABLE 2
The Virogene Program: Simultaneous Viral DNA and Antigen Detection
PROGRAM:
Virogene TECH: DJB DATE: 07/22/88
Station Time
Event No. Hold (minutes) Mix Temp (OC) Solution
1.0 N Clear
10.0 N 110 Denature oven
0.3 N Pad
0.1 N Clear
0.1 N Pad
0.1 N Clear
0.3 N Pad
1.0 N Reagent alcohol
0.1 N Pad
1.0 N Reagent alcohol
1.0 N Pad
0.5 N Enzyme
10.0 N 40 Chamber
0.6 N Pad
0.1 N Buffer
0.6 N Pad
0.3 N 95% ethanol
0.6 N Pad
0.3 N Reagent alcohol
0.6 N Pad
0.1 N Reagent alcohol
0.5 N Pad
2.0 N Probe or Primary
8.0 N 110 Denature oven
3.0 N Cool down
20.0 N 37 Chamber
0.1 N Probe wash
1.0 N Pad
1.0 N Probe wash
0.6 N Pad
0.1 N Probe wash
0.6 N Pad
2.0 N Probe wash
3.0 N Chamber
0.6 N Pad
0.1 N Buffer
1.0 N Pad
1.0 N Detection system
20.0 N 37 Chamber
0.6 N Pad
0.2 N Buffer
0.6 N Pad
0.2 N Distilled water
1.0 N Pad
0.5 N Chromogen
5.0 N 45 Chamber
0.6 N Pad
0.1 N Distilled water
1.0 N Pad
1.0 N Chromogen
001
002
003
004
005
006
007
008
009
010
011
012
013
014
015
016
017
018
019
020
021
022
023
024
025
026
027
028
029
030
031
032
033
034
035
036
037
038
039
040
041
042
043
044
045
046
047
048
049
050
06
19
12
06
12
06
12
05
12
05
12
13
18
11
10
11
03
11
05
11
05
11
14
19
00
18
07
11
07
08
07
08
07
18
08
10
09
15
18
11
10
08
02
11
16
18
11
02
09
16
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
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TABLE 2-Continued
PROGRAM:
Virogene TECH: DJB DATE:07/22/88
Station Time
Event No. Hold (minutes) Mix Temp (OC) Solution
051 18 N 5.0 N 45 Chamber
052 09 N 0.6 N Pad
053 02 N 0.1 N Distilled water
054 09 N 0.6 N Pad
055 02 N 0.1 N Distilled water
056 09 N 1.0 N Pad
057 01 N 1.5 N Hematoxylin
058 09 N 1.0 N Pad
059 02 N 0.1 N Distilled water
060 09 N 0.6 N Pad
061 02 N 0.1 N Distilled water
062 09 N 1.0 N Pad
063 10 N 0.6 N Buffer
064 09 N 0.6 N Pad
065 02 N 0.1 N Distilled water
066 09 N 0.6 N Pad
067 02 N 0.1 N Distilled water
068 09 N 1.0 N Pad
Total time for completion = 118.8 minutes = 2 hours.
lovirus antibody to the early nuclear antigen were both diluted 1:50 in the primary
antibody diluent. Rabbit anti-herpes simplex virus types 1 and 2 antibodies were
obtained already prediluted. Rabbit anti-adenovirus antibody to the hexon common
antigen was diluted 1:200 in the primary antibody diluent. Primary antibody incuba-
tions were carried out for 15 minutes at 480 Centigrade. We detected these primary
antibodies with a universal peroxidase reagent, which is a mixture of horseradish
peroxidase conjugated anti-mouse and anti-rabbit antibodies [6]. The secondary
antibody reagent was also reacted for 15 minutes at 480 Centigrade. The chromogen
used was 3-amino, 9-ethyl carbazole (AEC), as previously described [6]. Nuclear
counterstaining was achieved with aqueous hematoxylin for 1.5 minutes. After the
program was complete, slides were dried, cover slipped with Crystal Mount, and
heated in an 800 Centigrade oven for ten minutes. Immunostaining on cover slips
containing adenovirus-infected tissue culture cells was performed by the procedure
described above, with the exception that the cover slips were not put through the
dewaxing steps.
Viral Gene Detection
When colorimetric in situ DNA hybridization was carried out alone, we employed a
modification ofourpreviouslydescribed method [7,9]. Thebasic Virogene program for
our hybridization technique takes about two hours to run (Table 2). The probe for the
HSV genome consisted of two sequences of the HSV 1 (3.0 and 8.0 kb) and one
sequence ofthe HSV 2 (16.0 kb) genome. The CMV probe was made from a mixture
of two sequences of the CMV genome, one 17.2 kb and the other, 25.2 kb. Fragment
size ranged from 150 to 300 base pairs for both the herpes simplex virus (HSV) and
CMV probes, as estimated bygel electrophoresis. Adenovirus probe was from genomic
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adenovirus 5 DNA. Fragment size ranged from 150 to 300 base pairs as estimated by
gel electrophoresis. Cloned human papillomavirus types 6, 11, 16, and 18 DNA probes
ranged from 100 to 300 bases in length. The HSV, CMV, adenovirus, and papilloma
probes were diluted to 0.5 ,g/ml in 45 percent formamide hybridization cocktail.
Slides with five-micron tissue sections were prepared identically to those described
above for immunocytochemistry. Tissues were digested with freshly prepared pepsin, 2
mg/ml in 0.12 N HCI with 2.5 ml BRIJ/liter, at 400 Centigrade for 10.0 minutes.
Following this step, the tissues were washed in 1 x automation buffer with 25 percent
acetone and then with 95 percent ethanol.
Because of the viscosity of the hybridization cocktail, the capillary gaps had some
difficulty in taking up the probe. This problem was overcome by increasing the time in
station 14 to 2.0 minutes in order to assure adequate filling of the gaps. With this
increase in time, only 50 microliters ofprobe per slide were needed to cover the sections
immobilized on both sides of a capillary gap. Tissue and probe DNA melting was
achieved in 8.0 minutes with the high-temperature oven set at 1100 Centigrade.
Following denaturation, the slides were cooled down for 3.0 minutes at room
temperature and then incubated at 37.00 Centigrade for 20.0 minutes. This interval
was an adequate amount of time for significant hybridization. To remove the hybridi-
zation cocktail and wash the slides, a 1 x Probe Wash solution containing 25 percent
acetone was used. It was observed that contacting the capillary gaps with the probe
wash before removing the cocktail helped the capillary gaps to drain better. Heating
the probe wash in the wet chamber for a few minutes at 370 Centigrade also helped the
capillary gaps to clear the probe.
The detection system used for this study was alkaline phosphatase-avidin diluted
1:200 in 1 x automation buffer with 0.1 percent BSA, 1 mg/ml sodium azide, and 3
micromolar magnesium chloride. The slides were incubated in the detection system for
20 minutes at 370 Centigrade. The chromogen used (McGadey reagent) was made by
adding 200 microliters of a 25 mg/ml solution of p-iodonitrotetrazolium violet (INT)
in a 50/50 solution ofdimethylformamide and distilled water, and100 microliters of a
50 mg/ml solution of 5-bromo-4-chloro-3-indolyl phosphate p-toliudine salt (BCIP) in
dimethylformamide, to 30 ml of Tris saline, pH 9.5. Total time of incubation with the
chromogen was usually for 10.0 minutes at 45.00 Centigrade. The amount of positive
staining was dependent on the amount of time the slides were left in the chromogen;
more staining was observed with a longer time of incubation (up to 2.0 hours), but
background also increased. Slides were washed in distilled water containing 2.5 ml of
30 percent BRIJ 35 solution and 25 percent methanol. Nuclei were counterstained
with aqueous hematoxylin for 1.5 minutes. After completion of a run, the slides were
dried, cover slipped with Crystal Mount, and heated in an 800 Centigrade convection
oven for ten minutes. DNA hybridization was performed on tissue culture cells
infected with adenovirus in a way similar to that described above, with the exception
that the tissues did not need to be dewaxed.
Simultaneous Viral Gene and Antigen Detection
We also found that the Virogene program (Table 2) and machine set-up for in situ
DNA hybridization could also be used for automated viral antigen detection. Endoge-
nous peroxidase was blocked by adding 3 percent hydrogen peroxide to the reagent
alcohol in station 5; this addition did not affect the DNA probe signal. Pronase and
Auto/Zyme were still used for digestion in station 13 to detect the CMV and adenovirus
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FIG. 1. Color photograph ofthe Fisher Code-On Molecular Pathology system.
Immunocytochemistry
In situ DNA Hybridization
station 1 station 2 station 3 station 4 station 5 station 6 station 0
Hematoxylin Distilled 95% Methanol/ Reagant Clearing Cool
H20/BRIJ Alcohol Peroxide Alcohol Agent Down
Chamber
station 7 station 8 station 9 station 10 station 1 1 station 12
Probe Blotter Blotter Automation Blotter Blotter
Wash Butfer
station 13 station 14 station 15 station 16 | station 17 | station 18 station 19
Enzyme Primary Detection Chromogen
Digestion Antibody System Incubation High
|mOfOtt' nonnoonooo| ifinntonnot I 11 Chamber Temperature no1 BEznnnnononno 11.l.I...l.l...._ 1 O ven
DNA
Probe
FIG. 2. Basic reagent format used to set up the Fisher Code-On system, showing that the machines can be
arranged to do both immunocytochemistry and DNA hybridization.
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FIG. 3. Diagram ofthe capillary action cycle and its relationship to the hybridization cycle.
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FIG. 4. Photomicrograph of CMV-infected gas-
tric mucosal cells detected by DNA hybridization,
using the Virogene program (160 x).
FIG. 5. Photomicrograph of CMV-infected gas-
tric mucosal cells from section adjacent to those in
Fig. 4, as demonstrated by immunocytochemistry
employing the Virocode program (160 x).
FIG. 6. Photomicrograph demonstrating DNA FIG. 7. Photomicrograph of a section adjacent to
hybridization for a herpes simplex viral infection of that of Fig. 6, illustrating HSV antigen detection
the esophagus, using the Virogene program with the Virogene program (160 x). Figures 6 and 7
(160 x). were taken from slides produced simultaneously in
the same Virogene program run.
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FIG. 8. Photomicrograph of a benign vulvar
condyloma, demonstrating the HPV types 6 or 11
DNA, using the Virogene program (250 x).
FIG. 9. Photomicrograph ofa tissue section taken
adjacent to that of Fig. 8, illustrating the HPV
antigen by the Virocode program (250 x).
L ~ ~ ~ ~~~~~ ~ ~ ~~~ ~~ ~ ~~~~~~a ) . .....^-----
FIG. 10. Photomicrograph ofadenovirus-infected FIG. 11. Photomicrograph showing immuno-
tissue culture cells as demonstrated with a DNA staining for the hexon antigen in an adenovirus
probe, using the Virogene program (250 x). hepatitis with the Virocode program (160 x).
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antigens, respectively. Primary antibody was placed in the reagent isolon in station 14.
Use ofthe isolons allowed us to place primary antibodies and DNA probes in station 14
but in separate wells; this placement would allow simultaneous staining ofviral antigens
or DNA in separate capillary gaps. The holder containing separate antibody and DNA
probe-filled gaps was then robotically moved to the high-temperature oven in station 19.
The primary antibodyand DNA probes wereheated in thehigh-temperature oven setat
1100 Centigrade. Because ofthis high temperature, about 40-50 percent ofthe volume
was lost in the antibody-filled gaps, but little was lost in the probe-filled gaps because of
the high viscosity ofthe probe cocktail. Tissue sections were mounted on the bottom of
the Probe-On glass slides near the painted triangles, so that this loss in volume did not
uncover the tissue. An isolon placed in station 15 allowed the antibody-filled gaps to be
treated with the universal peroxidase reagent, while the probe-treated gaps received
avidin-alkaline phosphatase. AEC was still used as thechromogen for antigen detection
and BCIP/INT for gene probe localization. The use of a three-laned reagent isolon
allowed us to have separate compartments for the two chromogens and to detect tissue
antigens with AEC and viral genes with BCIP/INT simultaneously. The Virogene
program could therefore be run so that viral DNA and antigens could be detected in
different tissues located in separate capillary gaps in the same assay.
ControlsforAutomated Viral Antigen and Gene Detection
For antigen detection, negative controls consisted of incubating with the primary
antibody diluent alone. We also used antibodies against a certain virus on tissues
known to be infected with a different virus; this procedure provided us with informa-
tionabout thespecificity ofourantisera. Thenegativecontrols forviral DNAdetection
included incubation of the slides with the probe cocktail alone. We also incubated
probes against the DNA of one virus with tissue known to be infected with another
virus. These negative controls provided us with information about whether or not our
DNA detection system was specific for the different viruses.
Microscopic Examination andPhotography
Slides were examined and photographs were taken by means of a standard Zeiss
photomicroscope.
RESULTS
Cytomegalovirus
Nine cases oftissues known to be infected with cytomegalovirus were reviewed and
studied. These cases included autopsy and surgical cases ofpatients with CMV colitis,
gastritis, pleuritis, and pneumonitis. In all ninecases, cytomegalovirus wasdetected by
both immunocytochemistry and in situ DNA hybridization techniques (Table 3). The
CMV early antigen was detected by automation in cells with and without cytopathic
changes, in agreement with results previously reported by manual methods [2].
Staining was almost always intranuclear, although some intracytoplasmic inclusions
were detected by this method. Hybridization was also positive in the same cells and
tissues that were positive for antigen. With molecular hybridization, both intranuclear
and intracytoplasmic inclusions were found to stain clearly and consistently [2,3,4].
Cells with and without cytopathic changes consistent with CMV were detected with
the CMV DNA probe [4]. Intracytoplasmic inclusions were found in some cells
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TABLE 3
Number of Cases Positive with Both in Situ Hybridization and Immunocytochemistry
No. Positive with
Virus No. of Cases Immunocytochemistry DNA Hybridization
Cytomegalovirus 9 9 9
Herpes Simplex 4 4 4
Adenovirus 3 3 3
Papillomavirus 7 3 7
without any intranuclear staining; some cells with just one or two cytoplasmic
inclusions could be detected by this method. In situ hybridization produced a slightly
higher number ofpositive cells than the immunochemical stain. Becauseofthe amount
of pronase digestion used to detect the antigen, the morphology of the CMV-infected
cells could not be studied as well as with the molecular probes, which required milder
pepsin pretreatment. The results were identical when the rapid one-hour and 30-
minute previously described Virocode assay was compared to the two-hour immunocy-
tochemical method run under the high-temperature conditions of the Virogene DNA
hybridization program (Table2). Figures 4 and 5 show CMV-positivecells detected by
both techniques.
Herpesvirus
Four cases oftissues known to be infected with herpesvirus were used for the study.
These cases included herpes pneumonitis, adrenalitis, hepatitis, esophagitis, and
splenitis. Herpesvirus was detected by both methods (Table 3). For some ofthe cases
used, there was nosignificant difference between the methods, while for other cases the
probe did much better at detecting the virus. Cytoplasmic inclusions were better
visualized with in situ hybridization. Herpesvirus was observed in both epithelial as
well as mesenchymal tissue compartments with either ofthe methods. Figures 6 and 7
show herpes simplex virus staining by these techniques. Antibodies against herpesvirus
used in the two-hour Virogene program produced slightly less inclusion staining than
they did in the 1.6-hour Virocode program. It is likely that some denaturation of the
antibody may have taken place during the high-temperature step.
Papillomavirus
Seven cases of vulvar tissue known to contain koilocytosis, condylomatous growth,
and carcinoma in situ (one case) were studied. Human papillomavirus (HPV) was
detected by either of the methods employed in this study; however, only three cases
were positive with the antibodies used (Table 3). The antibody used mainly stained
rare cells in the stratum granulosum, although some cells in the deeper parts of the
epidermis stained, as was previously described [5,10,11,12,13]. Staining was focal and
rare, and many cells demonstrating clear koilocytosis failed to stain positively. Some
antigen-positive areas were also seen in the stratum corneum. In situ DNA hybridiza-
tion provided many more positive cells and was much more general in distribution;
HPV DNA was detected in the superficial as well as the deep layers ofthe epidermis,
indicating that the viral genome but not the antigen is more abundant throughout the
layers. This finding is consistent with results described previously by manual methods
[14,15]. Type 6 and type 11 DNA were observed in histologically diagnosed condylo-
ma, while DNA for types 16 and 18 were observed in the one specimen with combined
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koilocytosis, dysplasia, and carcinoma in situ; the probe-positive nuclei were observed
in the condylomatoses area but not in the dysplastic or carcinomatous zones. Figures 8
and 9 show results ofboth methods for papillomavirus detection. In situ hybridization
was observed to be far better for the identification ofpapilloma virus by automation in
standard surgical specimens. Viral inclusion staining was lost when the primary
antibodies were subjected to 1100 Centigradepreheating in theVirogeneprogram. It is
probable that not all antibodies will be capable ofwithstanding high temperatures in
the media in which we diluted them.
Adenovirus Automated Tissue Culture Analysis
A549 cells infected for 24 hours with adenovirus type 2 showed strong nuclear
localization with the probe for the adenovirus genome (Fig. 10). Much less signal was
detected with the anti-hexon antiserum; this finding is related to the six-year period of
refrigeration of this antibody. Two cases of formalin-fixed tissue with adenovirus
pneumonitis and hepatitis, culture-positive for types 2 and 5 adenovirus, were studied.
The two cases were positive with both gene probe and immunoassay technology (Table
3). The probe showed strong nuclear localization of the viral genome as previously
reported [1], and the antibody showed comparable nuclear and cytoplasmic localiza-
tion. Figures 10 and 11 show examples of the in situ hybridization on tissue culture
cells and immunostaining for adenovirus hepatitis, respectively. No differences in
staining were seen when these anti-hexon antibodies were used in the Virocode or the
Virogene program. The advantage of the longer program is that viral DNA could
simultaneously be localized in a separate capillary gap, using a single protocol. This
single advantage overcame the inconvenience of the extra half hour in processing
time.
DISCUSSION
This paper describes the first combined automated immunocytochemical and in situ
hybridization viral detection system, whose procedures are completed in two hours or
less on the same run. This streamlined use of automation provides significant
diagnostic advantages to the research virologist and the clinical morphologist alike.
Viral detection in cells and tissue substrates can now be completed rapidly, accurately,
and in large quantities. The Code-On Molecular Pathology system is capable of
simultaneously performing 30 different immunoassays or gene probe detections in any
combination. Many different tissue specimens as well as viral types can be studied at
the same time and on the same machine. This capacity allows batteries ofgene probes
or antibodies to be completed on individual unknown tissue specimens, and the results
are ready for comparative evaluation in one diagnostic session.
Both immunocytochemistry and in situ DNA hybridization have proved to be
effective ways of detecting DNA viruses in surgical and autopsy specimens. In some
cases, DNA hybridization produces far better results than immunocytochemistry.
Herpesvirus, for instance, is detected very well by both methods but is consistently
detected with stronger straining when biotinylated gene probe technology is used. In
situ DNA hybridization forcytomegalovirus DNA detects intracytoplasmic inclusions
better than immunocytochemistry. This result is expected, since the monoclonal
antibody used in this study is directed against an early antigen whose localization
predominates in the nucleus. DNA probe technology is by far the better method to
study papillomavirus in tissue fixed in formalin, as the antigens detected by the
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antibody were found mostly in the superficial areas ofthe lesions, while papilloma viral
genetic information could be detected throughout most of the layers of the epidermis;
less than one-half of the cases used stained positive for the antigen. Our conclusion is
that immunocytochemically identifiable antisera against early papillomavirus antigens
will have to be developed before antigen-based detection technology can approach the
sensitivity of presently available gene probe methodology.
This study shows that four DNA viruses can be detected easily and rapidly by the
methods of in situ DNA hybridization and immunocytochemistry. The majority of
infected cells were accurately and rapidly detected with our programs, although
increasing the primary antibody incubation or the DNA hybridization times could
further improve the intensity of the signal. Both techniques are capable of providing
the anatomist, microbiologist, or pathologist with two sets of unique biologic informa-
tion, and therefore both are helpful in the diagnosis and study of viral pathogens and
their association with disease states. It may be economically advisable to use antigen
detection as a screening test for the virus and then to use a confirmatory DNA probe
analysis if any uncertainty remains. This procedure may not always be practical,
because antigen may not always be detected, as in the case of papillomavirus. Gene
probe technology was easier to perform because a single combination of enzyme
predigestion, cellular DNA denaturation, probe hybridization, and detection produced
equivalent high-quality staining in all four viruses. Immunocytochemistry required
more specialized conditions for enzyme predigestion and a prolonged search for
primary antisera that worked in formalin-fixed tissues.
In order for molecular pathology to advance into the age of automation, it is ideal to
have one instrument, capable of performing both in situ hybridization and immunocy-
tochemistry, which employs a single programmed series of events. We have found that
this breakthrough can be accomplished because selected primary antibodies can
survive the 1100 Centigrade temperatures used during DNA denaturation. This
high-temperature survival is evidenced by the fact that horseradish peroxidase-
conjugated secondary antibodies can specifically recognize these primary antibodies
forming tissue immune complexes despite those drastic conditions. Polyclonal second-
ary antibodies can be selected to recognize extremely heat-insensitive epitopes on the
primary antibody, thereby allowing simultaneous tissue gene and antigen detection.
Antibodies are not as fragile as has been thought in the past. We have been able to run
immunocytochemical studies using the temperature conditions of our two-hour DNA
hybridization (Virogene) program with some loss in antigenic signal but no increase in
background noise if the primary antibody was properly diluted. The only drawback of
the present system is that 40 percent of the primary antibody volume is lost during the
high-temperature phase of the program. This volume loss can be significantly
diminished by shortening the denaturing time without losing hybridization signal.
The molecular basis for the surprising high-temperature survival of the antibodies
used in this study will require further investigation. We do not yet know how general or
restricted this property of immunoglobulins is. We know that primary rabbit IgG,
guinea pig IgG, and monoclonal IgG1 antibodies are capable of working under the
conditions ofthis study. Preliminary results from our laboratory indicate that standard
primary rabbit antibodies, raised against CEA orS100, and monoclonal antibodies
against muscle-specific actin are capable of surviving the hybridization program,
although some diminished staining can be noted. Further work is needed to determine
if the primary antibody diluent imparts this survivability or if it represents an inherent
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property ofimmune molecules. What we have observed is that, after heating in a 1100
Centigrade oven for eight minutes and cooling to 370 Centigrade for 20 minutes,
significant numbers of primary immune complexes remain intact at the site of their
tissue antigen. After eight minutes at 1100 Centigrade, the air temperature between
the oven walls and the capillary gaps achieved maximum temperatures of 95-1000
Centigrade, which were sufficiently high to denature probe and tissue-bound target
viral DNA molecules in adjacent capillary gaps. Whether all the signal detected in the
final result was solely the product ofimmune complexes formed in the first ten minutes
as the slides heated or whether immunoglobulins actually survive 95-1000 Centigrade
temperatures to react during the subsequent 20 minutes at 370 Centigrade is presently
unknown. Preliminary evidence indicates that the latter is true, since no signal is
detected in the areas oftissue uncovered as the volume ofthe primary antibody is lost
in the high-temperature-oven step.
In the future, improved automated methods for the anatomic diagnosis of viral
pathogens may revolutionize clinical virology. At the present time, tissue culture is
often the primary screening method used for viral diagnostics. This system is often
fruitful, as in the case of herpes simplex virus identification; time-consuming,
especially when cytomegalovirus is cultured; or consistently negative when the
pathogen is a papillomavirus. Present viral screening techniques can be revolutionized
if a single automated screening method is developed for probing cells, extracts, or
tissue sections, immobilized on planar microscope slides, with gene or immune probes.
These substrates can then be rapidly examined with a standard light microscope or
image analyzer in two hours or less to yield permanent, enzyme-generated, qualitative
or quantitative information, which then directs the choice ofselective media to obtain
the highest percentage yield ofviral growth. In the future, the "gold standard" ofviral
tissue culture can then become a confirmatory rather than a front-line screening test.
This study pioneers the identification of an initial set of important DNA viruses in
surgical and autopsy material and is intended to demonstrate the first unified system
forcombined viral gene and antigen detection. Through a processofcontinued primary
antibody and gene probe selection, we foresee the eventual development of the
Code-On Molecular Pathology system into a unified approach for the anatomic
diagnosis ofall DNA and RNA viruses. With this paper, the once separate diagnostic
fields ofautomated immunocytochemistry and DNA hybridization are now united into
a single molecular discovery system.
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